
|Articles|May 19, 2015
- Genitourinary (Issue 2)
- Issue 2
Trends in PSA Utilization in Primary Care Physicians
Author(s)Ryan Werntz, MD
Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses a study which examined trends in prostate-specific antigen (PSA) utilization in primary care physicians.
Advertisement
Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses a study which examined trends in prostate-specific antigen (PSA) utilization in primary care physicians.
<<<
Articles in this issue
about 11 years ago
Use of ARN-509 in Prostate Cancerabout 11 years ago
Abiraterone Plus Low-Dose Prednisone Lowers PSA in High-Risk M0 CRPCabout 11 years ago
Multiparametric MRI Effective, Affordable for Prostate Cancer Detectionabout 11 years ago
Study Illuminates Role of AR-V7 in Carcinogenesisabout 11 years ago
PSA Screening Drops 50% Following USPSTF Recommendationabout 11 years ago
Urine-Based Diagnostic Effectively Identifies Prostate Cancerabout 11 years ago
AR-V7 as a Biomarker in CRPCAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5
































